Akebia Therapeutics (AKBA)

Akebia Therapeutics (AKBA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• AKBA last traded at $0.71, -4.81% on the day.
• Akebia Therapeutics: market cap $195.78M, P/E -6.6, revenue $219.06M over the last four quarters, next earnings 2026-11-05.
• Over the past year AKBA returned -66.36%; year to date -56.12%.

Updated 2026-11-03 00:48 UTC